Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00624910 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy
A Phase 2 study, sponsored by Innocoll.
- Completed
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT00624910 is a Phase 2 study that has completed, run by Innocoll. The registered enrollment target is 54 participants.
The verdict
NCT00624910, a Phase 2 study, has completed, sponsored by Innocoll.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the CollaRx Bupivacaine implant is safe and effective in reducing the amount of narcotic pain medication needed to control pain during the first 24 hours after abdominal hysterectomy surgery.
Interventions
- DRUG placebo
- DRUG Bupivacaine Collagen Sponge (CollaRx®)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2007-12-27 |
| Est. Completion | 2008-09-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00624910
The ClinicalTrials.gov registry entry for NCT00624910 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Innocoll, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00624910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00624910 about?
NCT00624910 is a clinical study titled "Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy". The purpose of this study is to determine whether the CollaRx Bupivacaine implant is safe and effective in reducing the amount of narcotic pain medication needed to control pain during the first 24 hours after abdominal hysterectomy surgery.
What is the current status of trial NCT00624910?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2007-12-27. Estimated completion is 2008-09-05.
What interventions are being tested in trial NCT00624910?
The interventions under investigation include: placebo (DRUG), Bupivacaine Collagen Sponge (CollaRx®) (DRUG).
Who is sponsoring clinical trial NCT00624910?
This trial is sponsored by Innocoll, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.